…
Balance Labs, Inc. operates as a consulting firm that provides business development and consulting services to startup and development-stage businesses in the United States and internationally. The company offers services that help businesses in various industries improve and fine-tune their business models, sales and marketing plans, and internal operations, as well as make introductions to professional services, such as business plan writing, accounting firms, and legal service providers. It also assists in the development and execution of various services, such as business model development, including marketing research, naming, and branding; plan writing; financial modeling; website and mobile app development; employee and board member recruitment; patent/trademark filing assistance; product or service development; product production; marketing material development; product or service placement; celebrity endorsements; and introductions to professional services, such as legal and accounting. The company was incorporated in 2014 and is headquartered in Miami Beach, Florida. Balance Labs, Inc. is a subsidiary of Balance Holdings, LLC.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Balance Labs Inc (BLNC.US) is an issuer quoted on the OTC Pink market and has limited public filings and corporate disclosures, making its core operations and financial condition difficult to verify. Its long-term prospects would depend on clarifying a business plan, securing financing and achieving execution milestones, outcomes that could support upside for investors if management demonstrates sustainable revenue or strategic partnerships.
Significant risks include very low trading liquidity, high financing and execution risk, potential shareholder dilution and regulatory and market uncertainty common to OTC Pink companies.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -31.77M | -0.53M | -0.38M | -0.77M | -0.81M |
| Minority interest | - | - | - | 0.00M | 0.01M |
| Net income | -31.77M | -0.53M | -0.38M | -1.28M | -1.03M |
| Selling general administrative | 0.22M | 0.09M | 0.06M | 0.27M | 0.40M |
| Selling and marketing expenses | - | - | 0.06M | - | - |
| Gross profit | 0.01M | -0.19M | -0.06M | 0.20M | 0.48M |
| Reconciled depreciation | - | - | - | 0.00M | 0.00M |
| Ebit | - | -0.76M | -0.38M | -0.54M | -0.57M |
| Ebitda | -13.11M | -0.27M | -0.12M | -0.54M | -0.56M |
| Depreciation and amortization | - | 0.49M | 0.12M | 0.00M | 0.00M |
| Operating income | -13.11M | -0.27M | -0.12M | -0.02M | 0.22M |
| Other operating expenses | 13.11M | 0.27M | 0.12M | 0.27M | 0.40M |
| Interest expense | 0.21M | 0.23M | 0.22M | 0.23M | 0.24M |
| Interest income | - | - | 0.01M | 0.00M | 0.05M |
| Net interest income | -0.21M | -0.23M | -0.24M | -0.23M | -0.19M |
| Income tax expense | - | - | -0.12M | 0.51M | 0.22M |
| Total revenue | 0.01M | 0.00M | 0.04M | 0.25M | 0.62M |
| Total operating expenses | 13.11M | 0.09M | 0.12M | 0.27M | 0.40M |
| Cost of revenue | - | 0.19M | 0.06M | 0.05M | 0.15M |
| Total other income expense net | -18.66M | -0.26M | -0.27M | -0.75M | -1.03M |
| Net income from continuing ops | -31.77M | -0.53M | -0.45M | -0.77M | -0.81M |
| Net income applicable to common shares | - | - | - | -0.77M | -0.80M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 0.40M | 0.10M | 0.22M | 0.43M | 1.01M |
| Other current assets | - | - | 0.11M | 0.00M | 0.16M |
| Total liab | 3.77M | 5.17M | 4.76M | 4.59M | 4.41M |
| Total stockholder equity | -3.38M | -5.07M | -4.54M | -4.16M | -3.33M |
| Other current liab | 2.91M | 1.72M | 1.01M | 0.91M | 0.95M |
| Common stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Capital stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | -37.65M | -5.88M | -5.36M | -4.97M | -4.14M |
| Other assets | - | - | - | - | 0.02M |
| Cash | 0.36M | 0.01M | 0.11M | 0.24M | 0.23M |
| Total current liabilities | 3.77M | 5.17M | 4.76M | 4.11M | 3.94M |
| Current deferred revenue | - | - | - | -2.92M | - |
| Net debt | 0.14M | 2.52M | 2.36M | 2.22M | 2.22M |
| Short term debt | 0.50M | 2.54M | 2.47M | 1.98M | 1.98M |
| Short long term debt | 0.54M | 2.54M | 2.47M | 1.98M | 1.98M |
| Short long term debt total | 0.50M | 2.54M | 2.47M | 2.46M | 2.44M |
| Other stockholder equity | 34.27M | 0.81M | 0.81M | 0.81M | 0.81M |
| Total current assets | 0.40M | 0.10M | 0.22M | 0.43M | 0.43M |
| Long term investments | - | - | - | 0.00M | 0.57M |
| Net tangible assets | - | - | - | -4.16M | -3.33M |
| Short term investments | 0.04M | 0.08M | 0.11M | 0.15M | 0.55M |
| Net receivables | - | - | 0.00M | 0.04M | 0.20M |
| Long term debt | - | - | - | 0.48M | 0.47M |
| Inventory | - | - | - | - | -0.16M |
| Accounts payable | 0.36M | 0.91M | 1.28M | 1.22M | 1.01M |
| Non currrent assets other | - | - | - | - | 0.02M |
| Non current assets total | 0.00M | 0.00M | 0.00M | 0.00M | 0.59M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | 0.00M | - | -0.02M | -0.20M |
| Change to liabilities | - | - | - | 0.27M | 0.30M |
| Total cashflows from investing activities | - | - | - | - | -0.20M |
| Net borrowings | 0.60M | 0.06M | - | - | 0.48M |
| Total cash from financing activities | 0.60M | 0.06M | - | 0.03M | 0.48M |
| Change to operating activities | - | - | - | 0.00M | -0.00M |
| Net income | -31.77M | -0.53M | -0.38M | -0.77M | -0.81M |
| Change in cash | 0.35M | -0.10M | -0.12M | 0.01M | 0.22M |
| Begin period cash flow | 0.01M | 0.11M | 0.24M | 0.23M | 0.01M |
| End period cash flow | 0.36M | 0.01M | 0.11M | 0.24M | 0.23M |
| Total cash from operating activities | -0.26M | -0.16M | -0.12M | 0.01M | -0.06M |
| Depreciation | - | 0.01M | - | 0.00M | 0.00M |
| Other cashflows from investing activities | - | - | - | - | -0.14M |
| Change to inventory | - | - | - | -0.27M | -0.18M |
| Change to account receivables | - | 0.00M | 0.04M | -0.02M | -0.02M |
| Other cashflows from financing activities | 0.60M | 0.06M | - | - | 0.41M |
| Change to netincome | - | - | - | 0.51M | 0.45M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M |
| Change in working capital | 0.35M | 0.34M | 0.21M | 0.25M | 0.27M |
| Stock based compensation | 12.70M | 0.00M | - | - | - |
| Other non cash items | 18.46M | 0.03M | 0.05M | 0.53M | 0.48M |
| Free cash flow | -0.26M | -0.16M | -0.12M | 0.01M | -0.07M |
Sector: Industrials Industry: Consulting Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BLNC Balance Labs Inc |
- -% |
1.12 | - | - | 12103.52 | 79.24 | 160.76 | -32.27 |
| EXPGF Experian PLC |
- -% |
38.90 | 26.59 | 19.34 | 4.43 | 6.44 | 4.99 | 14.01 |
| EXPGY Experian plc PK |
0.68 1.73% |
39.92 | 26.45 | 19.30 | 4.41 | 6.43 | 4.99 | 14.01 |
| VRSK Verisk Analytics Inc |
5.59 2.93% |
196.30 | 28.72 | 21.88 | 7.52 | 74.89 | 9.06 | 16.91 |
| EFX Equifax Inc |
5.21 2.90% |
184.60 | 30.32 | 17.18 | 3.05 | 4.62 | 3.96 | 13.37 |
Balance Labs, Inc. operates as a consulting firm that provides business development and consulting services to startup and development-stage businesses in the United States and internationally. The company offers services that help businesses in various industries improve and fine-tune their business models, sales and marketing plans, and internal operations, as well as make introductions to professional services, such as business plan writing, accounting firms, and legal service providers. It also assists in the development and execution of various services, such as business model development, including marketing research, naming, and branding; plan writing; financial modeling; website and mobile app development; employee and board member recruitment; patent/trademark filing assistance; product or service development; product production; marketing material development; product or service placement; celebrity endorsements; and introductions to professional services, such as legal and accounting. The company was incorporated in 2014 and is headquartered in Miami Beach, Florida. Balance Labs, Inc. is a subsidiary of Balance Holdings, LLC.
| Name | Title | Year Born |
|---|---|---|
| Mr. Michael D. Farkas | President, CEO & Chairman | 1972 |
| Ms. Carmen Villegas | Secretary & Director | 1988 |
| Mr. Joel Kleiner | Chief Financial Officer | 1988 |
| Mr. Alan Campbell | Chief Executive Officer | 1977 |
| Mr. Alexander Farkas | President & COO | 2002 |
| Mr. Joel Kleiner | Chief Financial Officer | 1989 |
| Yechiel Baron | General Counsel | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.